Quarterly report pursuant to Section 13 or 15(d)

Acquisitions, Investments and Licenses - Equity Method Investments Narrative (Details)

v3.5.0.2
Acquisitions, Investments and Licenses - Equity Method Investments Narrative (Details)
$ in Millions
9 Months Ended
Sep. 30, 2016
USD ($)
Schedule of Equity Method Investments [Line Items]  
Total assets of equity method investees $ 432.8
Total (liabilities) of equity method investees (173.8)
Net (losses) of equity method investees (132.3)
Market value $ 57.1
Pharmsynthez  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 17.00%
Cocrystal  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 8.00%
Sevion  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 3.00%
Non-Invasive Monitoring Systems, Inc.  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 1.00%
Neovasc  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 4.00%
VBI Vaccines Inc  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 17.00%
InCellDx, Inc  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 27.00%